PMG
COYA icon

Private Management Group’s Coya Therapeutics COYA Stock Holding History

Private Management Group’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.25M Buy
384,217
+15,121
+4% +$70K 0.06% 182
2026
Q1 		$1.45M Buy
369,096
+88,829
+32% +$415K 0.04% 190
2025
Q4 		$1.63M Buy
+280,267
New +$1.7M 0.05% 185

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Private Management Group's COYA Position: Q2 2026 in Review

Private Management Group increased its Coya Therapeutics (COYA) stake by 4.1% in Q2 2026, buying an estimated $70K and bringing the position to 384,217 shares worth $2.25M. The position accounts for 0.06% of the portfolio, ranked #182.

Private Management Group first reported a position in COYA in Q4 2025 and has held it in 3 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Private Management Group held 384,217 shares of Coya Therapeutics worth $2.25M as of Q2 2026.
  • Private Management Group bought 15,121 Coya Therapeutics shares in Q2 2026, an estimated $70K.
  • Coya Therapeutics made up 0.06% of Private Management Group's portfolio in Q2 2026, its #182 holding.
  • Private Management Group first reported a position in Coya Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Private Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.